Massive study tracks safety of MS drugs in over 10,000 patients
NCT ID NCT05767736
Summary
This study aims to understand the long-term safety of several medications used to control multiple sclerosis (MS). Researchers will analyze health records from over 10,500 people with MS who are taking drugs like Vumerity or Tecfidera. The main goal is to track and compare the rates of serious side effects, such as severe infections or cancers, among the different treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Cambridge, Massachusetts, 02142, United States
Conditions
Explore the condition pages connected to this study.